Patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and high body mass index ...

There’s no “free ticket” to keep smoking with the idea of quitting later—some changes may be irreversible, experts say.

The paper compares the current peripheral transradial trajectory to that of the coronary space in the mid-2000s.

The findings could potentially enable patients to be identified and treated before symptoms of ATTR-CM emerge.

Things like early menarche, preeclampsia, and endometriosis didn’t reclassify risk in women ages 45-69. The question is: why?

The 2025 physician fee schedule (PFS) announced by the Centers for Medicare and Medicaid Services (CMS) last month is set to ...

The reason for the disparity is unknown but is not believed to be genetic. Female athletes appear to be at the lowest risk.

The findings hint at the potential need for serial measurements in patients who are being considered for Lp(a)-lowering therapies.

Greater weight loss was linked to greater savings, which may be directionally correct but isn’t necessarily the whole story.

The optimal revascularization choice may differ between women and men, but low numbers of women prevent firm conclusions.

Guidelines still contain strong recommendations for aspirin’s use, but some are calling for new trials to confirm benefits.

Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.